“…Included studies were performed in 12 provinces in Iran (Khorasan Razavi, Tehran, Kerman, Fars, Mazandaran, West Azerbaijan, Sistan and Baluchistan, Hamadan, Kohgiluyeh and Boyer-Ahmad, Chaharmahal and Bakhtiari, Khuzestan, and Ardabil), and most studies were done in Khorasan Razavi and Fars (n = 3 per province), as well as Tehran, Kerman, and Mazandaran (n = 2 per province). Among 19 included studies [ [26] , [27] , [28] , [29] , [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] , [43] , [44] ], 8226 apparently healthy blood donors were tested regarding T. gondii -specific IgG and/or IgM antibodies, among which 32.9% (95% CI: 25.3%–41.6%) were seropositive only for IgG, 1.4% (95% CI: 0.9%–2.1%) were seropositive only for IgM, and 1.7% (95% CI: 1.3%–2.1%) were positive for both IgG and IgM antibodies ( Fig. 2 A–C).…”